Sample Quality Sample Clauses

Sample Quality. 3.1. The Purchaser is responsible for providing a sample of suitable quality for testing as the quality of test results will be compromised if samples are not of an adequate standard. 3.2. Samples in the following sub-standard conditions will not be accepted. The report will state why the sample was not accepted and will incur a charge: 3.2.1. Samples taken at gestational ages less than stated in the User Guide INF1135 3.2.2. Haemolysed samples (for fetal genotyping from maternal plasma) 3.2.3. Leaking, broken or samples contaminated by leaking samples 3.2.4. Inadequate blood volume (see User Guide INF1135) 3.2.5. Sample sent in incorrect type of tube (see User Guide INF1135) 3.2.6. Inadequate labelling of sample tube / or referral form 3.2.7. Maternal blood samples must not be older than 3 days from date of venepuncture for fetal RhD/C/c and E genotyping on arrival at the NHSBT IBGRL laboratory 3.2.8. Maternal blood samples must not be older than 2 days from date of venepuncture for fetal Xxxx genotyping on arrival at the NHSBT IBGRL laboratory 3.2.9. Amniotic fluid samples must not be older than 7 days on arrival at the NHSBT IBGRL laboratory 3.2.10. Samples sent too early in gestation unless it has been pre-agreed with IBGRL (see User Guide INF1135) 3.2.11. Samples suspected of being used for any testing prior to being sent to NHSBT 3.2.12. Samples with addressograph labels– see User Guide INF1135 3.2.13. Hand written alterations on either the sample or request form – see User Guide INF1135 3.2.14. Samples of amniotic fluid or CVS DNA which have been in transit more than seven days upon receipt at the NHSBT IBGRL laboratory. 3.2.15. Maternal plasma aliquots which are not frozen upon receipt at the NHSBT IBGRL laboratory 3.3. Sample labelling and request form completion: Information regarding sample labelling requirements and request forms is also detailed within the IBGRL User Guides found at xxxx://xxxxx.xxxxx.xx.xx/. In the event the Purchaser fails to adhere to the labelling and sample requirements, NHSBT reserves the right to charge the Purchaser a fee as detailed within the Price List. These charges apply for samples where: 3.3.1. A sample has been rejected on receipt 3.3.2. A concession for testing has been requested by the Purchaser following initial rejection on receipt. 3.3.3. A sample has been tested on a concession, requested by the purchaser, but subsequently rejected by IBGRL during the testing process 3.4. When the Purchaser requires Servi...
AutoNDA by SimpleDocs
Sample Quality. 3.1. The Purchaser is responsible for providing a sample of suitable quality for testing as the quality of test results will be compromised if samples are not of an adequate standard. 3.2. Samples in the following sub-standard conditions may not be accepted. The report will state why the sample was not accepted: 3.2.1. Severely haemolysed samples 3.2.2. Leaking, broken or samples contaminated by leaking samples 3.2.3. Inadequate blood volume (see User Guide INF1136) 3.2.4. Sample sent in incorrect type of tube (see User Guide INF1136) 3.2.5. Inadequate labelling of sample tube / or referral form 3.3. Sample labelling and request form completion: Information regarding sample labelling requirements and request forms is also detailed within the IBGRL User Guides found at xxxx://xxxxx.xxxxx.xx.xx/. In the event the Purchaser fails to adhere to the labelling and sample requirements, NHSBT reserves the right to reject the samples. 3.4. When the Purchaser requires Services, they will provide a request form to NHSBT for each sample to be analysed. Samples must be accompanied by the appropriate signed and completed request form (FRM5891) as outlined in the department User Guide, INF1136. The request form has a guide for completion of the form (INF1451) available at xxxx://xxxxx.xxxxx.xx.xx/. Request forms are the basis of the correct identification of the patient. The points of identification provided on the request form must match the information provided on the sample. IBGRL will not accept referrals with an inadequate request form or sample labelling. Preferred minimum patient identification: (Surname and first name are one identifier) ▪ Surname / family name and first name(s) in full. ▪ Date of birth. ▪ Unique identification number e.g. NHS number, hospital number (the same number must be on both the tube and the form). 3.5. Date of venepuncture / sampling. The form must also identify the Purchaser / Requester including contact details, the reason for the test and relevant diagnosis. The form must be signed by the Purchaser or person with authority to request the test. The user guide explains sample labelling requirements, sample volumes and request form completion. This information can be found at xxxx://xxxxx.xxxxx.xx.xx/. 3.6. Samples should be labelled, dated and signed by the person taking them. 3.7. The request form must be completed with clinical information as requested and the expected date of delivery where applicable.

Related to Sample Quality

  • Image Quality You are responsible for the image quality of any Image that you transmit. If an Image that we receive from you or for deposit to your Account is not of sufficient quality to satisfy our image quality standards as we may establish them from time to time, we may reject the Image without prior notice to you. Each Image must include the front and back of the Item and the following information must be clearly readable: amount, payee name, drawer signature, date, check number, account number, routing and transit number, MICR (Magnetic Ink Character Recognition) line, and any endorsement or other information written on the check.

  • Service Quality The Transfer Agent shall maintain a quality control process designed to provide a consistent level of quality and timeliness for its call center, correspondence services and transaction processing.

  • Use; Quality Control a. Neither party may alter the other party’s trademarks from the form provided and must comply with removal requests as to specific uses of its trademarks or logos. b. Each party agrees to use, and to cause its Permitted Sublicensees to use, the other party’s trademarks only in good faith and in a dignified manner consistent with such party’s use of the trademarks. Upon written notice to the breaching party, the breaching party has 30 days of the date of the written notice to cure the breach or the license will be terminated.

  • Quality Assurance/Quality Control Contractor shall establish and maintain a quality assurance/quality control program which shall include procedures for continuous control of all construction and comprehensive inspection and testing of all items of Work, including any Work performed by Subcontractors, so as to ensure complete conformance to the Contract with respect to materials, workmanship, construction, finish, functional performance, and identification. The program established by Contractor shall comply with any quality assurance/quality control requirements incorporated in the Contract.

  • Product Quality (a) Tesoro warrants that all Products delivered under this Agreement or any Purchaser Order shall meet the latest applicable pipeline specifications or otherwise mutually agreed upon specifications for that Product upon receipt at the applicable Terminal and contain no deleterious substances or concentrations of any contaminants that may make it or its components commercially unacceptable in general industry application. Tesoro shall not deliver to any of the Terminals any Products which: (i) would in any way be injurious to any of the Terminals; (ii) would render any of the Terminals unfit for the proper storage of similar Products; (iii) would contaminate or otherwise downgrade the quality of the Products stored in commingled storage; (iv) may not be lawfully stored at the Terminals; or (v) otherwise do not meet applicable Product specifications for such Product that are customary in the location of the Terminal. If, however, there are Products that do not have such applicable specifications, the specifications shall be mutually agreed upon by the Parties. Should Tesoro’s commingled Products not meet or exceed the minimum quality standards set forth in this Agreement or any applicable Terminal Service Order, Tesoro shall be liable for all loss, damage and cost incurred thereby, including damage to Products of third parties commingled with Tesoro’s unfit Products. (b) TLO shall have the right to store compatible Products received for Tesoro’s account with Products belonging to TLO or third parties in TLO’s commingled storage tanks. TLO shall handle Tesoro’s fungible Products in accordance with TLO’s prevailing practices and procedures for handling such Products. The quality of all Products tendered into commingled storage for Tesoro’s account shall be verified either by Tesoro’s refinery analysis or supplier’s certification, such that Products so tendered shall meet TLO’s Product specifications. All costs for such analysis shall be borne solely by Tesoro. TLO shall have the right to sample any Product tendered to the Terminals hereunder. The cost of such sampling shall be borne solely by TLO. All Products returned to Tesoro shall meet or exceed Product specifications in effect on the date the Products are delivered to Tesoro. Notwithstanding any other provision herein, any and all Products that leave the Terminals shall meet all relevant ASTM, EPA, federal and state specifications, and shall not leave the Terminals in the form of a sub-octane grade Product. (c) TLO shall exercise reasonable care to ensure that all Products delivered by third parties into commingled storage with Tesoro’s Products meet applicable Product specifications for such Product that are customary in the location of the Terminal. In the event that Tesoro’s Products are commingled with third-party Products that do not meet or exceed the minimum quality standards set forth in this Agreement or any Terminal Service Order, TLO shall be liable for all loss, damage and cost incurred thereby.

  • Tax-Free Qualification (a) Each of Trident, Parent and Merger Subs shall use its respective reasonable best efforts to, and cause each of their respective Subsidiaries to, (i) cause the Mergers, taken together, to be treated as an “exchange” described in Section 351(a) of the Code, (ii) cause the Trident Merger to qualify as a “reorganization” within the meaning of Section 368(a) of the Code and (iii) to obtain the opinion of counsel referred to in Exhibit C (including by taking the actions described in Exhibit C). Each of Trident, Parent and Merger Subs shall use its respective reasonable best efforts not to, and shall use its reasonable best efforts not to permit any of its respective Subsidiaries to, take any action (including any action otherwise permitted by this Section 6.16) that would prevent or impede (A) the Mergers, taken together from being treated as an “exchange” described in Section 351(a) of the Code and (B) the Trident Merger from qualifying as a “reorganization” within the meaning of Section 368(a) of the Code. (b) Sun shall use its reasonable best efforts to, and cause each of its Subsidiaries to, (i) cause the Mergers, taken together, to be treated as an “exchange” described in Section 351(a) of the Code and (ii) to obtain the opinion of counsel referred to in Exhibit C (including by taking the actions described in Exhibit C). Sun shall use its reasonable best efforts not to, and shall use its reasonable best efforts not to permit any of its Subsidiaries to, take any action (including any action otherwise permitted by this Section 6.16) that would prevent or impede the Mergers, taken together, from qualifying as an “exchange” described in Section 351(a) of the Code. (c) Unless otherwise required pursuant to a “determination” within the meaning of Section 1313(a) of the Code, each of the parties shall report the Mergers for U.S. federal income tax purposes collectively as an “exchange” within the meaning of Section 351(a) of the Code. Parent will (and following the Closing will cause the Trident Surviving Corporation and the Sun Surviving Corporation, as applicable, to) file all required information with its Tax Returns and maintain all records required for Tax purposes.

  • Quantitative Analysis Quantitative analysts develop and apply financial models designed to enable equity portfolio managers and fundamental analysts to screen potential and current investments, assess relative risk and enhance performance relative to benchmarks and peers. To the extent that such services are to be provided with respect to any Account which is a registered investment company, Categories 3, 4 and 5 above shall be treated as “investment advisory services” for purposes of Section 5(b) of the Agreement.”

  • Power Quality Neither the facilities of Developer nor the facilities of Connecting Transmission Owner shall cause excessive voltage flicker nor introduce excessive distortion to the sinusoidal voltage or current waves as defined by ANSI Standard C84.1-1989, in accordance with IEEE Standard 519, or any applicable superseding electric industry standard. In the event of a conflict between ANSI Standard C84.1-1989, or any applicable superseding electric industry standard, ANSI Standard C84.1-1989, or the applicable superseding electric industry standard, shall control.

  • Due Qualification Seller is duly qualified to do business as a foreign corporation, is in good standing, and has obtained all necessary licenses and approvals in all jurisdictions in which the ownership or lease of its property or the conduct of its business requires such qualification.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!